{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:03:46Z","timestamp":1791147826364,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ymgme.2012.09.024","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T05:51:20Z","timestamp":1348811480000},"page":"705-710","source":"Crossref","is-referenced-by-count":97,"title":["Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III"],"prefix":"10.1016","volume":"107","author":[{"given":"Jessica","family":"de Ruijter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minke H.","family":"de Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Wagemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan M.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Bradley","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"van Vlies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2012.09.024_bb0005","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin. Hematol."},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2012.09.024_bb0030","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0040","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with Hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0045","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1542\/peds.2009-1728","article-title":"Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up","volume":"125","author":"Gabrielli","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0050","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-0004.2009.01324.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age \u2014 a sibling control study","volume":"77","author":"McGill","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0055","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1651-2227.2011.02385.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: a 3-year follow-up","volume":"101","author":"Tylki-Szymanska","year":"2012","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ymgme.2009.07.015","article-title":"Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II","volume":"98","author":"Wang","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry","volume":"171","author":"D'Aco","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0070","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype\u2013phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0075","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10545-010-9199-y","article-title":"Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype","volume":"33","author":"Valstar","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0080","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/clinchem\/47.4.780","article-title":"Diagnosis of alpha-L-iduronidase deficiency in dried blood spots on filter paper: the possibility of newborn diagnosis","volume":"47","author":"Chamoles","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0085","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2006.02.013","article-title":"Newborn screening for lysosomal storage disorders","volume":"88","author":"Meikle","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jmg.2010.088096","article-title":"Screening patients referred to a metabolic clinic for lysosomal storage disorders","volume":"48","author":"Fuller","year":"2011","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0095","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.cca.2011.06.001","article-title":"Practical and reliable enzyme test for the detection of mucopolysaccharidosis IVA (Morquio Syndrome type A) in dried blood samples","volume":"412","author":"Camelier","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0100","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/clinchem\/47.12.2098","article-title":"Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper","volume":"47","author":"Chamoles","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0105","series-title":"Epidemiology of lysosomal storage diseases: an overview","author":"Fuller","year":"2006"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0110","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1373\/clinchem.2009.141622","article-title":"Newborn screening of lysosomal storage disorders","volume":"56","author":"Marsden","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0115","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/ac0100650","article-title":"Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography\/electrospray ionization mass spectrometry: application to clinical enzymology","volume":"73","author":"Gerber","year":"2001","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0120","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2004.035907","article-title":"Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening","volume":"50","author":"Li","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0125","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.clinbiochem.2009.01.022","article-title":"Implementation of newborn screening for Krabbe disease: population study and cutoff determination","volume":"42","author":"Orsini","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0130","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.cca.2012.04.012","article-title":"Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: Application to a small-scale population study for five lysosomal storage disorders","volume":"413","author":"Orsini","year":"2012","journal-title":"Clin. Chem. Acta"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-009-9036-3","article-title":"Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I","volume":"33","author":"Tomatsu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymgme.2009.10.001","article-title":"Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry","volume":"99","author":"Tomatsu","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ab.2007.05.016","article-title":"Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography\/turbo ionspray ionization tandem mass spectrometry","volume":"368","author":"Oguma","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0150","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nmeth0408-291","article-title":"Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans","volume":"5","author":"Lawrence","year":"2008","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1750-1172-6-84","article-title":"Biomarker analysis of Morquio syndrome: identification of disease state and drug responsive markers","volume":"6","author":"Martell","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0160","doi-asserted-by":"crossref","unstructured":"S. Tomatsu, A.M. Montano, T. Oguma, V.C. Dung, H. Oikawa, T.G. de Carvalho, M.L. Gutierrez, S. Yamaguchi, Y. Suzuki, M. Fukushi, K. Kida, M. Kubota, L. Barrera, T. Orii, Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry, J. Inherit. Metab. Dis. (in press), http:\/\/dx.doi.org\/10.1007\/s10545\u2013009\u20139013-x.","DOI":"10.1007\/s10545-009-9013-x"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2008.05.001","article-title":"Heparin cofactor II-thrombin complex: a biomarker of MPS disease","volume":"94","author":"Randall","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10545-010-9254-8","article-title":"Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases","volume":"34","author":"Langford-Smith","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0175","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/ajmg.a.34053","article-title":"Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome","volume":"155A","author":"Muschol","year":"2011","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2012.09.024_bb0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","article-title":"Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands","volume":"93","author":"Ruijter","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.09.024_bb0185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/humu.1189","article-title":"Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications","volume":"18","author":"Yogalingam","year":"2001","journal-title":"Hum. Mutat."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212003654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212003654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T07:44:09Z","timestamp":1594712649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212003654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1096719212003654"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.09.024","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}